Differences of Acute Prostatitis, Benign Prostatic Hypertrophy, and Prostate Cancer - Essay Example

Benign prostatic hypertrophy is a nonmalignant growth of the prostate that is generated by an overgrowth of the fibromuscular and epithelium flesh of the peri-urethral zone and the transition area. This illness is common in men aged fifty years and above. Its clinical presentation includes obstruction of urine flow, urethra compression, frequent urination, not being able to start urinating and leaking and urgency or dribbling (Zhou, Netto & Epstein, 2012). In regard to diagnostic testing, microscopic hematuria initial evaluation is done on a patient, the presence of palpable induration or nodularity of the prostate on digital rectal assessment reveals the condition. Prostate cancer does not cause any signs at all and can present at any level of the illness. In most cases, cancer occurs in the prostate gland periphery and the signs arise when they have developed to compress the urethra or attack the sphincter. Prostate cancer presents in urinary tract obstruction (LUTS) symptoms. The LUTS is in three distinct groups associated with the post-micturition symptoms, storage of urine and voiding (Tewari, 2013). In regard to diagnostic testing, prostate cancer is diagnosed using imaging techniques such as MRI to detect tumors that are clinically significant.

Education plan
Basic patient education tips a physician may offer include:
1. Urinating often and not allowing the bladder to be full
2. Avoidance of alcohol or caffeine-containing drinks
3. Avoidance of fluids before bedtime
4. Exercise daily
5. Taking of prescribed medication only, as some over-the-counter medications may hinder urinating.
The treatment of prostatitis is difficult because of the presence of inhibited penetration of most antibiotics across the prostatic epithelium and through the non-fenestrated prostatic capillaries to the infected fluids and tissues. The patient must be advised that the preferred drug is fluoroquinolone because of its quality of good penetration through the prostate. The time of antibiotic therapy is usually 2-4 weeks, and that depends on the severe nature of the illness. The patient is then reviewed for clinical symptoms and signs (Koda-Kimble & Alldredge, 2013).

When patients suffer from mild symptoms of benign prostatic hypertrophy there is no need for alarm but they should be careful. If they suffer from moderate symptoms then, there is the need for pharmaceutical intervention. In this case, the appropriate drugs include tamsulosin hydrochloride (Flomax) which helps to relax the prostatic urethral muscle and improve the flow of urine. In severe conditions, the process involves the use of invasive methods. This includes two techniques non-surgical invasive treatment and surgical treatment. In non-surgical treatment consist of transurethral needle ablation and transurethral microwave thermotherapy. The surgical treatment comprises of open prostatectomy, transurethral resection, and laser prostatectomy of the prostate and transurethral incision of the prostate (Koda-Kimble & Alldredge, 2013).

Patients suffering from prostate cancer are treated using a combination therapy of radiation and hormone therapy that is referred to as androgen deprivation therapy (ADT). In situations where the patient does not react to hormone therapy then the treatment provided is chemotherapy and other examinational options (Figg, Chau & Small, 2010). The patient is advised to visit the clinic regularly for the disease to be monitored.
In conclusion, the three diseases affect the prostrate, and they all require medical attention. It is important for the correct treatment to be given to stop the illness or reduce the severity of the disease. Read More